JP2016539148A5 - - Google Patents

Download PDF

Info

Publication number
JP2016539148A5
JP2016539148A5 JP2016536528A JP2016536528A JP2016539148A5 JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5 JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016536528 A JP2016536528 A JP 2016536528A JP 2016539148 A5 JP2016539148 A5 JP 2016539148A5
Authority
JP
Japan
Prior art keywords
alkyl
group
optionally substituted
phenyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016536528A
Other languages
English (en)
Japanese (ja)
Other versions
JP6457523B2 (ja
JP2016539148A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/075890 external-priority patent/WO2015082324A1/en
Publication of JP2016539148A publication Critical patent/JP2016539148A/ja
Publication of JP2016539148A5 publication Critical patent/JP2016539148A5/ja
Application granted granted Critical
Publication of JP6457523B2 publication Critical patent/JP6457523B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016536528A 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン Expired - Fee Related JP6457523B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13195720 2013-12-04
EP13195720.1 2013-12-04
PCT/EP2014/075890 WO2015082324A1 (en) 2013-12-04 2014-11-28 Sulfoximine substituted quinazolines for pharmaceutical compositions

Publications (3)

Publication Number Publication Date
JP2016539148A JP2016539148A (ja) 2016-12-15
JP2016539148A5 true JP2016539148A5 (enExample) 2017-11-30
JP6457523B2 JP6457523B2 (ja) 2019-01-23

Family

ID=49726564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016536528A Expired - Fee Related JP6457523B2 (ja) 2013-12-04 2014-11-28 医薬組成物のためのスルホキシイミン置換キナゾリン

Country Status (7)

Country Link
US (1) US10093660B2 (enExample)
EP (1) EP3077383B1 (enExample)
JP (1) JP6457523B2 (enExample)
AU (1) AU2014359456B2 (enExample)
CA (1) CA2929742C (enExample)
ES (1) ES2693520T3 (enExample)
WO (1) WO2015082324A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015257917C1 (en) * 2014-05-07 2019-03-14 Evotec International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
AR117788A1 (es) * 2019-01-14 2021-08-25 Pi Industries Ltd Compuestos de fenilamidina 3-sustituida, preparación y uso
CN112812136B (zh) * 2019-11-15 2022-04-12 武汉光谷亚太医药研究院有限公司 新型2,3-二氢化茚衍生化合物、制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987192A (en) 1974-01-07 1976-10-19 The Upjohn Company Compositions and process of treatment
US5602118A (en) 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
WO1995033746A1 (en) 1994-06-08 1995-12-14 E.I. Du Pont De Nemours And Company Cyclic sulfonamide herbicides
SE0102147D0 (sv) 2001-06-18 2001-06-18 Pharmacia Ab New methods
US20050080026A1 (en) 2001-10-29 2005-04-14 Arnd Steuernagel Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
JP2005527511A (ja) 2002-03-01 2005-09-15 ファイザー インコーポレイテッド 抗血管形成剤として有用なチエノピリジンのインドリル−尿素誘導体およびその使用法
GB0315587D0 (en) 2003-07-03 2003-08-13 Univ Dundee Anti-inflammatory assay and compounds
ES2611018T3 (es) 2004-04-08 2017-05-04 Dow Agrosciences Llc Sulfoximinas N-sustituidas insecticidas
EP1746099A1 (en) 2004-12-23 2007-01-24 DeveloGen Aktiengesellschaft Mnk1 or Mnk2 inhibitors
EP1899353A1 (en) 2005-06-22 2008-03-19 DeveloGen Aktiengesellschaft Thienopyrimidines for pharmaceutical compositions
KR20080107466A (ko) 2006-03-09 2008-12-10 파마코페이아, 인코포레이티드 대사 장애 치료용 8-헤테로아릴퓨린 mnk2 억제제
JP5302883B2 (ja) * 2006-04-07 2013-10-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 医薬組成物用のmnk1/mnk2阻害活性を有するチエノピリミジン
US20080039450A1 (en) 2006-06-22 2008-02-14 Jensen Annika J Compounds
DE102007024470A1 (de) 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren
WO2008141843A1 (en) * 2007-05-24 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
EP2231632A2 (en) 2008-01-25 2010-09-29 Syngenta Participations AG 2-cyanophenyl sulfonamide derivatives useful as pesticides
US20120232073A1 (en) 2009-11-23 2012-09-13 Santhosh Francis Neelamkavil Fused bicyclic pyrimidine derivatives and methods of use thereof
AR080328A1 (es) 2010-02-26 2012-03-28 Boehringer Ingelheim Int Tienopirimidinas que contienen un grupo alquilo sustituido inhibidoras de quinasas mnk1 y/o mnk2, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento de trastornos metabolicos tales como diabetes y obesidad, y trastornos hiperproliferativos, entre otros
UY33241A (es) * 2010-02-26 2011-09-30 Boehringer Ingelheim Int ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
AR088082A1 (es) 2011-10-13 2014-05-07 Lilly Co Eli Moduladores selectivos del receptor androgeno
EP2917185B1 (en) * 2012-11-09 2017-05-10 Evotec International GmbH Sulfoximine substituted quinazolines for pharmaceutical compositions
DK3013805T3 (en) * 2013-06-28 2018-04-23 Evotec Int Gmbh Sulfoximine-substituted quinazolines and their use as MNK1 and / or MNK2 kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2016515561A5 (enExample)
JP2013518107A5 (enExample)
JP2013542247A5 (enExample)
JP2016510326A5 (enExample)
JP2015508103A5 (enExample)
JP2013542261A5 (enExample)
JP2014532647A5 (enExample)
JP2015511609A5 (enExample)
JP2014511891A5 (enExample)
JP2016503797A5 (enExample)
JP2014528464A5 (enExample)
RU2016141569A (ru) Комбинации
JP2017517538A5 (enExample)
JP2019535723A5 (enExample)
HK1210771A1 (zh) 氮杂吲哚衍生物
JP2015509075A5 (enExample)
JP2017518360A5 (enExample)
JP2013518036A5 (enExample)
JP2012522841A5 (enExample)
JP2018525425A5 (enExample)
JP2015516419A5 (enExample)
JP2016515550A5 (enExample)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
JP2021503451A5 (enExample)
RU2018117499A (ru) Производные 6-[5-амино-6-(2-этоксиэтокси)-имидазо[4,5-b]пиридин-3-ил]никотинонитрила и их применение в качестве irak ингибиторов